Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses:
Research and development	$ 205,032	$ 822,444	$ 6,450,979	$ 2,774,924
General and administrative	1,874,578	814,218	4,387,284	2,955,371
Total operating expenses	2,079,610	1,636,662	10,838,263	5,730,295
Loss from operations	(2,079,610)	(1,636,662)	(10,838,263)	(5,730,295)
Other income (expense):
Interest income	1,033	8,597	4,896	22,868
Interest expense	(50,528)		(53,442)
Total other income (expense)	(49,495)	8,597	(48,546)	22,868
Net loss	$ (2,129,105)	$ (1,628,065)	$ (10,886,809)	$ (5,707,427)
Net loss per share of common stock, basic and diluted	$ (0.08)	$ (0.07)	$ (0.43)	$ (0.26)
Weighted-average shares used to compute basic and diluted net loss per share	26,146,220	24,128,060	25,191,359	21,623,648